Skip to content
HeyJared

Melanie Wolkoff Wachsman

Reporter

Indexed articles, last 90 days
4
Latest publication
Sep 18, 2026
Outlet visibility, for ADDitude
Top 500K sites
Earliest in this view
Jul 9, 2026

Latest articles

  1. Article · Sep 18, 2026 · By Melanie Wolkoff Wachsman

    Do ADHD Meds Stunt Growth? A New Stimulant Study Says No (opens the original)

    Excerpt · English

    Read excerpt

    ADHD stimulants have a negligible effect on adult height, according to a new study that tracked more than 64,000 children for nearly 30 years. Long-term stimulant use for ADHD negligibly affects adult height, according to a new cohort study published in Pediatric Research that tracked 64,775 children for up to 28 years.1 Parents making ADHD treatment decisions commonly worry that prescription stimulants will stunt their child’s growth. In a 2024 ADDitude survey of 11,000 readers, less than half

  2. Article · Aug 26, 2026 · By Melanie Wolkoff Wachsman

    Could ADHD Medications Treat Coexisting Depression and Anxiety? New Studies Say Yes. (opens the original)

    Excerpt · English

    Read excerpt

    Viloxazine, centanafadine, and other ADHD medications effectively reduce symptoms of coexisting depression and anxiety, suggest a new study and clinical trials. ADHD medications decrease antidepressant usage and reduce symptoms of depression and anxiety in people diagnosed with attention deficit, suggest findings from three new studies. Antidepressant and psychotropic medication use in adults often precedes an ADHD diagnosis; however, a new landmark study published in Acta Psychiatrica Scandinav

  3. Article · Jul 29, 2026 · By Melanie Wolkoff Wachsman

    Centanafadine Receives FDA Approval for the Treatment of ADHD (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Centanafadine (brand name: Simtriyo) is a first-in-class norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant approved to treat ADHD symptoms in adults and children aged 6 years or older. Centanafadine (brand name: Simtriyo), the first and only norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant has received U.S. Food and Drug Administration (FDA) approval for the treatment of ADHD in adult

  4. Article · Jul 9, 2026 · By Melanie Wolkoff Wachsman

    Study: Narcissistic Traits, Aggression, Low Self-Esteem Are Common but Unrelated in Boys with ADHD (opens the original)

    Excerpt · English

    Read excerpt

    Adolescent boys with ADHD are more likely to exhibit narcissistic traits and experience low self-esteem compared to their neurotypical peers, but these factors do not influence aggressive behaviors, according to a new study. Adolescent boys with ADHD may exhibit lower self-esteem, more narcissistic traits, and greater aggression than do boys without ADHD. However, narcissistic tendencies and low self-esteem do not directly influence aggressive behaviors, according to a new study published in the

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For ADDitude, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Melanie Wolkoff Wachsman